SCHEMBL12465669

SCHEMBL12465669

COc1ccc(-c2nn3ccc(Br)cc3c2C=CC=[N+](C)C)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPM1 P06748 1/20 0.35
ALK Q9UM73 1/20 0.35
PTGS1 P23219 1/20 0.33
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
BRD4 O60885 1/20 0.32
PTGS2 P35354 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
RPA1 P27694 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
USP2 O75604 1/20 0.31
MAPT P10636 1/20 0.31
PTPN11 Q06124 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12465668 1.00 NPM1 (0.35) NPM1ALKPTGS1NPC1RAB9A
SCHEMBL12465680 0.87 NPM1 (0.36) NPM1ALKPTGS1NPC1RAB9A
SCHEMBL12687660 0.86 NPM1 (0.37) NPM1ALKPTGS1NPC1RAB9A
Hydrochloric Acid SCHEMBL12465729 0.85 NPM1 (0.37) NPM1ALKPTGS1NPC1RAB9A
SCHEMBL12465648 0.84 NPM1 (0.37) NPM1ALKNPC1RAB9AALDH1A1
SCHEMBL12465649 0.84 NPM1 (0.37) NPM1ALKNPC1RAB9AALDH1A1
SCHEMBL9959559 0.82 KMT2A (0.40) NPM1ALKNPC1RAB9AALDH1A1
SCHEMBL9959511 0.79 KMT2A (0.43) NPM1ALKNPC1RAB9AALDH1A1
SCHEMBL9959512 0.79 KMT2A (0.43) NPM1ALKNPC1RAB9AALDH1A1
SCHEMBL12465739 0.76 HRH3 (0.37) NPC1RAB9AALDH1A1KDM4EPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493456-B2 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators UNIVERSITE DE MONTREAL (CA) 2016-11-15 US disclosed
US-20150197520-A1 PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS Université de Montréal 2015-07-16 US disclosed
US-9018395-B2 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators Université de Montréal (CA) 2015-04-28 US disclosed
US-20140057894-A1 PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS UNIVERSITE DE MONTREAL (CA) 2014-02-27 US disclosed
WO-2012100342-A1 PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS Université de Montréal (CA) 2012-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197520-A1 PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS MC4R, MC5R, MC1R NPM1 3336/4885ALK 1638/4885PTGS1 3406/4885
US-20140057894-A1 PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS MC4R, MC5R, MC1R NPM1 3409/4885ALK 1970/4885PTGS1 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.